Spyre Therapeutics Inc (SYRE)

Operating Expenses

$41.64M

Quarterly · Period ending: · USD

SYRE logo

SYRE Operating Expenses

Latest reported$41.64M
SYRE Quarterly Operating Expenses ($857.00K → $41.64M)
High-resolution chart · PNG

SYRE operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
41,639,000
45,641,000
102,419,000
11,641,000
41,935,000
53,567,000
61,253,000
55,392,000
44,147,000
47,774,000
45,914,000
18,337,000
159,934,000
18,456,000
18,840,000
18,427,000
22,573,000
25,306,000
23,584,000
6,839,000
6,822,000
18,209,000
22,776,000
18,123,000
21,560,000
19,022,000
21,909,000
22,146,000
18,622,000
17,657,000
15,305,000
12,243,000
12,048,000
9,755,000
8,108,000
9,259,000
8,199,000
7,313,000
6,790,000
7,450,000
6,868,000
5,426,000
5,582,000
4,490,000
4,859,000
2,469,000
3,181,000
3,140,000
1,726,000
857,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.